Hepatotoxicity induced by trastuzumab used for breast cancer adjuvant therapy: a case report

INTRODUCTION: Trastuzumab is generally considered a highly safe drug, but there have been cases of infusion reaction and cardiotoxicity. This report will present a rare case of hepatotoxicity induced by trastuzumab used for adjuvant therapy of human epidermal growth factor receptor type 2-positive b...

Descripción completa

Detalles Bibliográficos
Autores principales: Ishizuna, Kazuo, Ninomiya, Jun, Ogawa, Toshihisa, Tsuji, Eiichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307619/
https://www.ncbi.nlm.nih.gov/pubmed/25491149
http://dx.doi.org/10.1186/1752-1947-8-417

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4307619/
https://www.ncbi.nlm.nih.gov/pubmed/25491149
http://dx.doi.org/10.1186/1752-1947-8-417

Ejemplares similares